welcome esmo immuno-oncology 2024 esmo's journal portfolio resources resources elsevier’s oncology journal network 続きを読む elsevier’s oncology journal network highlights 続きを読む
The European Society for Medical Oncology (ESMO) is a non-profit professional medical oncology society in Europe. ESMO offers post-graduate education and training in clinical cancer care and research, and produces evidence-based recommendations for basic standards of cancer care. Website http://www...
Jordan K, Aapro M, Kaasa S, Ripamonti CI, Scotte F, Strasser F, Young A, Bruera E, Herrstedt J, Keefe D, Laird B, Walsh D, Douillard JY and Cervantes A: European Society for Medical Oncology (ESMO) position paper on supportive and palliative care. Annals of Oncology 29: 36-43,...
*Abstracts may also be submitted to the Cancer nursing track. Submissions in these categories will be reviewed by the European Oncology Nursing Society (EONS) Scientific Committee for selection and presentation in the EONS cancer nursing programme. Unless otherwise stated, submissions in the Cancer nur...
ESMO 2025 - European Society of Medical Oncology (ESMO) Congress 2025 Date: 17-21 October 2025 Venue: Messe Berlin (Berlin, Germany) The ESMO Congress is a highly influential global oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives fr...
The European Society for Medical Oncology (ESMO) 2024 was held in Barcelona from 13 to 17 September. The five-day event welcomed nearly 33,000 attendees and 598 speakers offering the latest cutting-edge data and high-quality training sessions in the field of oncology. Daniela Marín-Hernández ...
unveiled for the first time safety and efficacy data of IBI-354, an HER2 monoclonal antibody-camptothecin derivative conjugate that shows promising efficacy signals across a range of advanced solid tumors, during the European Society of Medical Oncology (ESMO) 2024 Congress. An HER2-targeted antibody...
The 2020 Congress of the European Society for Medical Oncology (ESMO) was another large meeting held solely in a virtual format due to the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. While we all have—to a certain extent—become used to the transfer of lar...
During this session, we will review the current precision oncology landscape with a focus on NSCLC and thyroid cancer, as well as the latest clinical research data on emerging biomarkers such as RET and NTRK. Session 2 Leading from the lab: pathology in focus With an increasi...
+ESMO is the leading European professional organisation for medical oncology. Comprising over 20,000 oncology professionals from over 150 countries, we are the society of reference for oncology education and information. We are committed to supporting our members to develop and advance in a fast-evol...